Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kewreshini Naidoo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|July 3, 2025
Antiretroviral therapy initiated during acute infection in women with HIV-1 clade C reduces anti-Tat antibody production and lowers CD8+ T cell activationThandeka I Kubheka, Kewreshini Naidoo, Kavidha Reddy, et al.
Plos One|June 2, 2023
Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA allelesAna Moyano, Bongiwe Ndlovu, Msizi Mbele, et al.
Plos One|October 10, 2023
Metabolic and mitochondrial dysregulation in CD4+ T cells from HIV-positive women on combination anti-retroviral therapyMatrona Akiso, Magdalene Ameka, Kewreshini Naidoo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2016
Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected PatientsChristina Thobakgale, Kewreshini Naidoo, Lyle R McKinnon, et al.
AIDS (London, England)|May 6, 2025
Altered mitochondrial mass and fatty acid uptake by NK cells in HIV-exposed uninfected children at 6 years of ageHope Mataramvura, Ana Jordan-Paiz, Kewreshini Naidoo, et al.
AIDS (London, England)|December 4, 2020
HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotypeMaja C Ziegler, Kewreshini Naidoo, Anais Chapel, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|July 3, 2025
Antiretroviral therapy initiated during acute infection in women with HIV-1 clade C reduces anti-Tat antibody production and lowers CD8+ T cell activationThandeka I Kubheka, Kewreshini Naidoo, Kavidha Reddy, et al.
Plos One|June 2, 2023
Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA allelesAna Moyano, Bongiwe Ndlovu, Msizi Mbele, et al.
Plos One|October 10, 2023
Metabolic and mitochondrial dysregulation in CD4+ T cells from HIV-positive women on combination anti-retroviral therapyMatrona Akiso, Magdalene Ameka, Kewreshini Naidoo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2016
Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected PatientsChristina Thobakgale, Kewreshini Naidoo, Lyle R McKinnon, et al.
AIDS (London, England)|May 6, 2025
Altered mitochondrial mass and fatty acid uptake by NK cells in HIV-exposed uninfected children at 6 years of ageHope Mataramvura, Ana Jordan-Paiz, Kewreshini Naidoo, et al.
AIDS (London, England)|December 4, 2020
HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotypeMaja C Ziegler, Kewreshini Naidoo, Anais Chapel, et al.
Pageof 1